Elkedonia is a biotech company dedicated to transforming antidepressant therapy.
Elkedonia has raised $12.9M in total funding. The most recent round was Seed. The last funding was announced in June 2025.
Elkedonia's investors include Bpifrance, Kurma Partners, ARGOBIO, Angelini Ventures, Carma Fund.
Elkedonia is headquartered in Strasbourg, France.
Elkedonia is a biotech company dedicated to transforming antidepressant therapy.
Elkedonia is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Elkedonia — Funding & Investors." VCBacked, June 11, 2025, https://www.vcbacked.co/company/elkedonia. Accessed September 15, 2026.
VCBacked. (2025). Elkedonia — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/elkedonia
{{cite web |title=Elkedonia — Funding & Investors |url=https://www.vcbacked.co/company/elkedonia |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated